glaxo aims profit fall
glaxosmithkline profits fall drugmaker recovery
cheap copies drugs paxil wellbutrin weak dollar profits confident drug pipeline deliver profits failure obesity drug executive garnier difficult
afternoon trade pence garnier absorbed lost generics managing grow continuing success forward performance terms pipeline progress discontinued experimental treatment obesity disappointing clinical trial glaxo relying treatments conditions cancer diabetes depression allergies lift pace disappointing
